Clinical Trial

Screening for Cancers in the Oral CAvity

Study acronym: IDECAB
Recruiting
View on ClinicalTrials.gov →
Summary
In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media). The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2013-10-07; most recent amendment 2023-02-07.
Status change: Not Yet Recruiting → Recruiting 2015-07-28
Trial Details
NCT Number NCT01958762
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Collaborators: Picardy - Regional health agency (ARS), Regional Council Picardie, Regional Observatory of Health and Social Issues in Picardie (OR2S), Association for the screening of diseases in Somme (Adema 80), Somme Cancer Registry
Conditions Oral Cavity Cancer
Enrollment 100 participants
Start Date 2013-10
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2023-02-08